Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Aviron's intranasal influenza vaccine begins phase III

Aug. 30, 1996

FDA approval requested for thymoglobin manufacturing process, facility

Aug. 30, 1996

STV: Possible antituberculosis and autoimmune disease therapy

Aug. 23, 1996

Immunomodulating peptides from BioChem Pharma

Aug. 23, 1996

Cel-Sci and U.S. Navy collaborate on malaria vaccine

Aug. 23, 1996

North American Vaccine/Abbott DTaP marketing agreement

Aug. 23, 1996

Acellular antiBortedella vaccine claimed by Institut Pasteur

Aug. 16, 1996

Oxygermylpropionic acid polymer reported by Sanwa Kagaku

Aug. 16, 1996

FDA approves expanded use of Acel-Imune

Aug. 16, 1996

CSL discloses HPV vaccine components

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...